News and Analysis | Published:

Food allergy drugs step up to Phase III

Nature Reviews Drug Discovery volume 15, pages 149150 (2016) | Download Citation

Two biotechs have carved out a regulatory pathway for what could become the first FDA-approved preventative peanut allergy therapies.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

About this article

Publication history




  1. Search for Katie Kingwell in:

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing